This protocol is judged by an institutional overview board, an unbiased team that assessments any clinical trials involving people. If a research consists of a Routine I drug, once the board approves the protocol as ethical, the scientists must apply for an investigational new drug (IND) selection in the FDA.When under the influence of the drug, t